Testicular cancer statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of testicular cancer, 2015-2017, UK

Deaths

Deaths from testicular cancer, 2015-2017, UK

 

Survival

Survive testicular cancer for 10 or more years, 2013-2017, England and Wales

Prevention

Preventable cases of testicular cancer are not known as it is not clearly linked to any preventable risk factors

  • There are around 2,300 new testicular cancer cases in the UK every year, that's more than 6 every day (2015-2017).
  • In males in the UK, testicular cancer is the 18th most common cancer, with around 2,200 new cases in 2017.
  • Testicular cancer accounts for 1% of all new cancer cases in males in the UK (2017).
  • Testicular cancer accounts for less than 1% of all new cancer cases in females and males combined in the UK (2017).
  • Incidence rates for testicular cancer in the UK are highest in males aged 30 to 34 (2015-2017).
  • Each year only 1% of all new testicular cancer cases in the UK are diagnosed in males aged 75 and over (2015-2017).
  • Since the early 1990s, testicular cancer incidence rates have increased by around a quarter (24%) in males in the UK (2015-2017).
  • Over the last decade, testicular cancer incidence rates have remained stable in males in the UK (2015-2017).
  • Around 1 in 10 testicular cancer cases are diagnosed at a late stage in Northern Ireland (2010-2014).
  • Most testicular cancers occur in descended testicles.
  • Incidence rates for testicular cancer are projected to rise by 12% in the UK between 2014 and 2035, to 10 cases per 100,000 males by 2035.
  • Testicular cancer in England is less common in males living in the most deprived areas.
  • Testicular cancer is more common in White males than in Asian or Black males.
  • An estimated 34,900 men who had previously been diagnosed with testicular cancer were alive in the UK at the end of 2010.

See more in-depth testicular cancer incidence statistics

  • There are around 65 testicular cancer deaths in the UK every year, that's more than 1 every week (2015-2017).
  • In males in the UK, testicular cancer is not among the 20 most common causes of cancer death, with around 65 deaths in 2017.
  • Testicular cancer accounts for less than 1% of all cancer deaths in males in the UK (2017).
  • Testicular cancer accounts for less than 1% of all cancer deaths in females and males combined in the UK (2017).
  • Mortality rates for testicular cancer in the UK are highest in males aged 50 to 54 (2015-2017).
  • Since the early 1970s, testicular cancer mortality rates have decreased by more than four-fifths (83%) in males in the UK.
  • Over the last decade, testicular cancer mortality rates have remained stable in males in the UK.
  • Mortality rates for testicular cancer are projected to fall by 35% in the UK between 2014 and 2035, to fewer than 1 death per 100,000 males by 2035.
  • Testicular cancer deaths in England are more common in males living in the most deprived areas.

See more in-depth testicular cancer mortality statistics

  • More than 9 in 10 (96.5%) of men diagnosed with testicular cancer in England survive their disease for one year or more (2013-2017).
  • More than 9 in 10 (95.3%) of men diagnosed with testicular cancer in England survive their disease for five years or more (2013-2017).
  • It is predicted that around 9 in 10 (91.3%) of men diagnosed with testicular cancer in England survive their disease for ten years or more (2013-2017).
  • Almost all men in England diagnosed with testicular cancer aged 15-49 survive their disease for five years or more, compared with more than two-thirds of men diagnosed aged 80 and over (2009-2013).
  • Testicular cancer survival is improving and has increased in the last 40 years in the UK, probably because of combination chemotherapy.
  • In the 1970s, around 7 in 10 men diagnosed with testicular cancer survived their disease beyond ten years, now it's around all men.
  • Five-year relative survival for testicular cancer in men is above the European average in England but similar to the European average in Wales, Scotland and Northern Ireland.
  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 215 UK males will be diagnosed with testicular cancer in their lifetime.
  • Testicular cancer is not clearly linked to any preventable risk factors.
  • No modifiable factors have been conclusively linked with testicular cancer risk, though many factors have been studied. The most well-established risk factor for testicular cancer is cryptorchidism.

See more in-depth testicular cancer risk statistics

  • 'Two-week wait' is the most common route to diagnosing testicular cancer.
  • ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ and ‘62 day wait’ are not met by any country for urological cancers.

See more in-depth testicular cancer diagnosis and treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.